Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mark W. Turrentine is active.

Publication


Featured researches published by Mark W. Turrentine.


Transplant Immunology | 2009

Effect of desensitization in solid organ transplant recipients depends on some cytokines genes polymorphism.

Andrew L. Lobashevsky; J.E. Manwaring; M.M. Travis; B.L. Nord; N.G. Higgins; Y.A. Serov; T.S. Arnoff; G.A. Hommel-Berrey; William C. Goggins; T.E. Taber; Charles Carter; Daniel Smith; Thomas C. Wozniak; J.A. O'Donnell; Mark W. Turrentine

Desensitization (DS) is widely used to decrease PRA in solid organs transplant candidates (TC). Various numbers of cycles of DS are required to reduce or eliminate donor specific antibodies (DSA). The goal of this study was to investigate if there was a correlation between polymorphism (PM) of some cytokine genes and intensity of DS required to make the recipient/donor cross match compatible. Thirty-one TCs were included in the study. Antibody specificity, percent of reactive antibodies (PRA) and serum concentration of cytokines were analyzed using the LUMINEX platform. PCR-SSP method was used for IL-1alpha, IL-1beta, IL-1R, IL-1Ralpha, IL-4Ralpha, IL-12, IFNgamma, TGFbeta1, TNFalpha, IL-2, IL-4, IL-6 and IL-10 gene PM analysis. Significant relationship between PM of genes encoding IL-4Ralpha, IFNgamma and IL-12 (p70) and susceptibility to DS was demonstrated (p=0.04, p=0.01 and p=0.05 respectively). Correlation between elevated serum level of IL-12 (p70) and A/A or C/A genotype at -1188 position was found in resistant to DS TCs (p=0.015). These results indicate that analysis PM of genes encoding IL-4R, IFNgamma and IL-12 enables to define the DS strategy in TCs more accurately regarding the number of plasmapheresis (PP) cycles and dose of intravenous immunoglobulin (IVIG).


Journal of the Pediatric Infectious Diseases Society | 2013

A Randomized, Controlled Trial of Catheter-Related Infectious Event Rates Using Antibiotic-Impregnated Catheters Versus Conventional Catheters in Pediatric Cardiovascular Surgery Patients

Elaine G. Cox; Chad A. Knoderer; Aimee Jennings; John W. Brown; Mark D. Rodefeld; Scott G. Walker; Mark W. Turrentine

: We conducted a randomized, controlled clinical trial to determine whether a difference in catheter-associated blood stream infection (CABSI) incidence existed between children who underwent cardiac surgery and had a central venous catheter impregnated with minocycline and rifampin versus those who had a conventional, nonimpregnated catheter after cardiac surgery. Due to a lower number of infections than expected, the study was terminated early. Among 288 evaluable patients, the rates of CABSI and line-related complications were similar between the 2 groups.


Journal of the American College of Cardiology | 2005

Acute hemodynamic effects of pacing in patients with fontan physiology: A prospective study

Brent J. Barber; Anjan S. Batra; Grant H. Burch; Irving Shen; Ross M. Ungerleider; John W. Brown; Mark W. Turrentine; Motomi Mori; Yi Ching Hsieh; Seshadri Balaji


Author | 2017

Performance of SynerGraft Decellularized Pulmonary Allografts Compared With Standard Cryopreserved Allografts: Results From Multiinstitutional Data

Steve Bibevski; Mark Ruzmetov; Randall S. Fortuna; Mark W. Turrentine; John W. Brown; Richard G. Ohye


Author | 2016

Tracheostomy Following Surgery for Congenital Heart Disease: 14-year Institutional Experience

Brian D. Benneyworth; Jenny M. Shao; A. Ioana Cristea; Veda L. Ackerman; Mark D. Rodefeld; Mark W. Turrentine; John W. Brown


Author | 2016

Tracheostomy after Surgery for Congenital Heart Disease: An Analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database

Christopher W. Mastropietro; Brian D. Benneyworth; Mark W. Turrentine; Amelia S. Wallace; Christoph P. Hornik; Jeffery P. Jacobs; Marshall L. Jacobs


Author | 2016

Vasoactive-ventilation-renal score reliably predicts hospital length of stay after surgery for congenital heart disease

Bradley Scherer; Elizabeth A. S. Moser; John W. Brown; Mark D. Rodefeld; Mark W. Turrentine; Christopher W. Mastropietro


Author | 2015

Pediatric Cardiac Tumors: A 45-year, Single Institution Review

Laura Linnemeier; Brian D. Benneyworth; Mark W. Turrentine; Mark D. Rodefeld; John W. Brown


Archive | 2013

Functional Depression in the Heart p38 Mitogen Activated Protein Kinase Mediates Both Death Signaling and

Daniel R. Meldrum; Meijing Wang; Ben M. Tsai; Mark W. Turrentine; Yousuf Mahomed; John W. Brown


Archive | 2013

to potential therapies Hypoxic pulmonary vasoconstriction in cardiothoracic surgery: basic mechanisms

Daniel R. Meldrum; Ben M. Tsai; Meijing Wang; Mark W. Turrentine; Yousuf Mahomed; John W. Brown

Collaboration


Dive into the Mark W. Turrentine's collaboration.

Top Co-Authors

Avatar

John W. Brown

Indiana University – Purdue University Indianapolis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Charles Carter

Houston Methodist Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Thomas C. Wozniak

Houston Methodist Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge